Key facts
- Hyivy Health’s last known valuation is $3.9M (Jan 2022).
- It has raised $3.0M; the latest was Seed Round in Oct 2025.
- Notable investors include Creative Destruction Lab, SOSV, University of Toronto, ventureLAB Innovation Centre, Innovation Factory (Hamilton) — 34 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 34 names
- ·Watchlist + deal alerts for Hyivy Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Hyivy Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hyivy Health
Developer of a remote therapeutic and monitoring system designed for pelvic and gynecological treatment. The company's system provides quantifiable data sets on the pelvic floor by using a device to conduct three different therapies tracked using multiple biosensors, enabling patients and their clinicians to treat, track, and predict conditions and symptoms.
- Sector
- Healthcare
- HQ
- Kitchener, Canada
- Founded
- 2019
- Employees
- 10
- Website
- hyivy.com/
- Ownership
- Privately Held (backing)
Hyivy Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hyivy Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hyivy Health in its N-PORT filings yet. We sweep new filings monthly.